Recall Enforment Report D-0603-2024
Recall Details
Multi event Drug Recall Enforcement Report Class II voluntary initiated by Viatris Inc, originally initiated on 04-30-2024 for the product Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10 The product was recalled due to failed impurities/degradation specifications. The product was distributed nationwide and the recall is currently completed.
Recall Enforcement Reports
Recall Number | Recall Initiation Date | Report Date | Recall Classification | Quantity | Product Description | Recall Reason | Status |
---|---|---|---|---|---|---|---|
D-0603-2024 | 04-30-2024 | 07-24-2024 | Class II | 3,694 bottles | Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10 | Failed Impurities/Degradation Specifications | Completed |
D-0602-2024 | 04-30-2024 | 07-24-2024 | Class II | 12,691 bottles | Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2040-10 | Failed Impurities/Degradation Specifications | Completed |